Allmed Medical released its 2026 interim report. Total operating revenue was 1.839 billion yuan, and net profit attributable to the parent company was 194 million yuan, a decrease of 6.3152 million yuan from the same period last year, down 3.16% year-on-year. Net cash flow from operating activities was negative 40.8978 million yuan, a decrease of 386 million yuan from the same period last year, down 111.85% year-on-year. The company's asset-liability ratio was 39.38%, gross margin was 31.20%, and ROE was 5.24%, all showing varying degrees of change. The number of shareholders was 38,800, and the top ten shareholders held 66.20% of the total share capital.
Allmed Medical Products Co Ltd Class ANet profit fell 3.16% year-on-year and operating cash flow turned deeply negative.